These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 10070893

  • 1. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
    McDaid HM, Cairns MT, Atkinson RJ, McAleer S, Harkin DP, Gilmore P, Johnston PG.
    Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
    [Abstract] [Full Text] [Related]

  • 2. [Relationship between overexpression of the RIalpha subunit of the cAMP-dependent protein kinase and clinicopathological features of lung cancer].
    Shi SS, He ZG, Shao K, Zhou F, Xiong MH, Huang W, Mu BD, Zhang CY, Zhang S, Sun YT, He J.
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):547-50. PubMed ID: 15555286
    [Abstract] [Full Text] [Related]

  • 3. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K, Tian X, Gu L, Tanimoto H, Underwood LJ, O'Brien TJ, Ohama K.
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [Abstract] [Full Text] [Related]

  • 4. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O, Hacker NF, Cho-Chung YS.
    Oncogene; 1999 Sep 02; 18(35):4999-5004. PubMed ID: 10490835
    [Abstract] [Full Text] [Related]

  • 6. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T, Shigemasa K, Arihiro K, Fujii T, Nagai N, Ohama K.
    Oncol Rep; 2005 Jun 02; 13(6):1153-8. PubMed ID: 15870936
    [Abstract] [Full Text] [Related]

  • 7. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
    Skålhegg BS, Johansen AK, Levy FO, Andersson KB, Aandahl EM, Blomhoff HK, Hansson V, Taskén K.
    J Cell Physiol; 1998 Oct 02; 177(1):85-93. PubMed ID: 9731748
    [Abstract] [Full Text] [Related]

  • 8. Loss of cables, a novel gene on chromosome 18q, in ovarian cancer.
    Dong Q, Kirley S, Rueda B, Zhao C, Zukerberg L, Oliva E.
    Mod Pathol; 2003 Sep 02; 16(9):863-8. PubMed ID: 13679449
    [Abstract] [Full Text] [Related]

  • 9. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.
    Gynecol Oncol; 2006 Dec 02; 103(3):831-40. PubMed ID: 16919315
    [Abstract] [Full Text] [Related]

  • 10. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P, Wu X, Chen W, Liu J, Wang X.
    Gynecol Oncol; 2007 Mar 02; 104(3):714-20. PubMed ID: 17204312
    [Abstract] [Full Text] [Related]

  • 11. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 12. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA, Lee KY, Liu Y, Emilion G, Finch J, Soosay AE, Charnock FM, Beck S, Dunham I, Mungall AJ, Ganesan TS.
    Oncogene; 2007 Feb 01; 26(5):683-700. PubMed ID: 16878154
    [Abstract] [Full Text] [Related]

  • 13. Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.
    Komiyama S, Kurahashi T, Ishikawa M, Tanaka K, Komiyama M, Mikami M, Udagawa Y.
    Oncol Rep; 2011 Apr 01; 25(4):1131-8. PubMed ID: 21249319
    [Abstract] [Full Text] [Related]

  • 14. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.
    Clin Cancer Res; 2001 Nov 01; 7(11):3457-64. PubMed ID: 11705863
    [Abstract] [Full Text] [Related]

  • 15. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 01; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 16. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
    Withoff S, van der Zee AG, de Jong S, Hollema H, Smit EF, Mulder NH, de Vries EG.
    Br J Cancer; 1999 Feb 01; 79(5-6):748-53. PubMed ID: 10070864
    [Abstract] [Full Text] [Related]

  • 17. Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer.
    Reed E, Yu JJ, Davies A, Gannon J, Armentrout SL.
    Clin Cancer Res; 2003 Nov 01; 9(14):5299-305. PubMed ID: 14614013
    [Abstract] [Full Text] [Related]

  • 18. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC, Lu KH.
    Clin Cancer Res; 2005 Sep 01; 11(17):6116-26. PubMed ID: 16144910
    [Abstract] [Full Text] [Related]

  • 19. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
    Ota T, Gilks CB, Longacre T, Leung PC, Auersperg N.
    Reprod Sci; 2007 Sep 01; 14(6):605-14. PubMed ID: 17959889
    [Abstract] [Full Text] [Related]

  • 20. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance].
    Cheng YX, Feng J, Zhang XY, Fu TY, Yao Y.
    Ai Zheng; 2004 Sep 01; 23(9):1026-30. PubMed ID: 15363195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.